Nix Protein Positively Regulates NF-κB Activation in Gliomas

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Lu, Yuntao ^a   Wang, Leyu ^a   He, Minyi ^a,b   Huang, Wenhua ^a   Li, Hong ^a   Wang, Yongkui ^a   Kong, Jiming ^c   Qi, Songtao ^a   Ouyang, Jun ^a   Qiu, Xiaozhong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MEMBRANE PROTEIN; MESSENGER RNA; NIX PROTEIN; PROTEIN BAX; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER GRADING; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOGENESIS; CELL HYPOXIA; CELL STRAIN U251; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; GEL MOBILITY SHIFT ASSAY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ONCOGENE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANOXIA; APOPTOSIS; ASTROCYTOMA; BCL-2-ASSOCIATED X PROTEIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MEMBRANE PROTEINS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84866309661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044559     Document Type: Article

References (33)

1. Ohgaki H, Kleihues P, (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109: 93-108.
2. Ziegler DS, Kung AL, Kieran MW, (2008) Anti-apoptosis mechanisms in malignant gliomas. J Clin Oncol 26: 493-500.
3. Wong ML, Kaye AH, Hovens CM, (2007) Targeting malignant glioma survival signalling to improve clinical outcomes. J Clin Neurosci 14: 301-308.
4. Sun S-Y, Hail N, Lotan R, (2004) Apoptosis as a novel target for cancer chemoprevention. Journal of the National Cancer Institute 96: 662-672.
5. Lefranc F, Brotchi J, Kiss R, (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 23: 2411-2422.
6. Koul D, Takada Y, Shen R, Aggarwal BB, Yung WKA, (2006) PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells. Biochemical and biophysical research communications 350: 463-471.
7. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, et al. (2004) NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 101: 10137-10142.
8. Shen H-M, Tergaonkar V, (2009) NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis: an international journal on programmed cell death 14: 348-363.
9. Sarkar FH, Li Y, Wang Z, Kong D, (2008) NF-kappaB signaling pathway and its therapeutic implications in human diseases. International reviews of immunology 27: 293-319.
10. Arlt A, Schafer H, (2002) NFkappaB-dependent chemoresistance in solid tumors. International journal of clinical pharmacology and therapeutics 40: 336-347.
11. Esencay M, Newcomb EW, Zagzag D, (2010) HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration. J Neurooncol 99: 33-40.
12. Angileri FF, Aguennouz MH, Conti A, La Torre D, Cardali S, et al. (2008) Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Cancer 112: 2258-2266.
13. Korkolopoulou P, Levidou G, Saetta AA, El-Habr E, Eftichiadis C, et al. (2008) Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. Human pathology 39: 1143-1152.
14. Mazure NM, Pouyssegur J, (2010) Hypoxia-induced autophagy: cell death or cell survival? Curr Opin Cell Biol 22: 177-180.
15. Zhang J, Ney PA, (2009) Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 16: 939-946.
16. Diwan A, Koesters AG, Odley AM, Pushkaran S, Baines CP, et al. (2007) Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proceedings of the National Academy of Sciences of the United States of America 104: 6794-6799.
17. Bacon AL, Harris AL, (2004) Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann Med 36: 530-539.
18. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL, (2001) HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 61: 6669-6673.
19. Bruick RK, (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proceedings of the National Academy of Sciences of the United States of America 97: 9082-9087.
20. Fei P, Wang W, Kim S-h, Wang S, Burns TF, et al. (2004) Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer cell 6: 597-609.
21. Galvez AS, Brunskill EW, Marreez Y, Benner BJ, Regula KM, et al. (2006) Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. The Journal of biological chemistry 281: 1442-1448.
22. Schweers RL, Zhang J, Randall MS, Loyd MR, Li W, et al. (2007) NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proceedings of the National Academy of Sciences of the United States of America 104: 19500-19505.
23. Zhang J, Ney PA (2010) Mechanisms and biology of BNIP3 and NIX. Antioxid Redox Signal.
24. Nihei N, Ichikawa T, Kawana Y, Kuramochi H, Kugoh H, et al. (1996) Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell-mediated chromosome transfer. Genes, chromosomes & cancer 17: 260-268.
25. Bacon AL, Fox S, Turley H, Harris AL, (2007) Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer. Oncogene 26: 132-141.
26. Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, et al. (2005) Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 11: 1021-1027.
27. Erkan M, Kleeff J, Esposito I, Giese T, Ketterer K, et al. (2005) Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24: 4421-4432.
28. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, et al. (2008) Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. The Journal of biological chemistry 283: 10892-10903.
29. Tracy K, Macleod KF, (2007) Regulation of mitochondrial integrity, autophagy and cell survival by BNIP3. Autophagy 3: 616-619.
30. Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, et al. (2001) Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. Neurologia medico-chirurgica 41: 187-195.
31. Coupienne I, Bontems S, Dewaele M, Rubio N, Habraken Y, et al. (2010) NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy. Biochem Pharmacol.
32. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
33. Xue J, Li X, Jiao S, Wei Y, Wu G, et al. (2010) Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology 138: 606-615.